Previous 10 | Next 10 |
SANUWAVE Health ( OTCQB:SNWV ): Q1 GAAP EPS of -$0.01. More news on: SANUWAVE Health, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
SUWANEE, Ga., May 21, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) reported financial results for the three months ended March 31, 2019 with the SEC on Monday, May 20, 2019. The Company will also host a conference call today, May 21, 2019 at 9:00 ...
Suwanee, GA, May 20, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV), an emerging medical technology company focused on the development and commercialization of noninvasive, biological response activating devices in regenerative medicine, today ...
SUWANEE, GA, May 16, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) announced today that the Company will release financial results for the first quarter ended March 31, 2019 next week. The Company will also host a conference call on Tuesday, May 21, 2...
Suwanee, GA, April 25, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB:SNWV), an emerging medical technology company focused on the development and commercialization of noninvasive, biological response activating devices in regenerative medicine, today comme...
Suwanee, GA, April 23, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) ( www.sanuwave.com ) announced they have entered North and South Carolina as their 5th and 6th markets in 2019, also hiring David Cummings to lead SANUWAVE in the Carolinas...
SUWANEE, GA / ACCESSWIRE / April 22, 2019 / SANUWAVE Health, Inc. (OTCQB: SNWV) ( www.sanuwave.com ) SANUWAVE Health, Inc. is an emerging regenerative medicine company focused on the development and commercialization of noninvasive, biological response activating devices for the repair and r...
SUWANEE, GA, April 10, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCBB: SNWV) is pleased to provide an update regarding the Company’s regulatory status in the worldwide sales and distribution of the company’s medical devices. In addition ...
Suwanee, GA, April 04, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCBB: SNWV) ( www.sanuwave.com ): SANUWAVE® is pleased to announce initial enrollment beginning this week in two company-sponsored studies. First, SANUWAVE is sponsoring an initial case ...
SUWANEE, GA, April 02, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV), an emerging medical technology company focused on the development and commercialization of noninvasive, biological response activating devices in regenerative medicine, received United S...
News, Short Squeeze, Breakout and More Instantly...
SANUWAVE is pleased to announce preliminary revenues of $7.0 million to $7.2 million for the second quarter ended June 30, 2024. This represents the highest quarterly revenues in company history. Q1 2024 revenue increased between 50% and 54% compared to Q2 2023. UltraMist revenues for Q2 2024...
Company to Pursue Alternate Plans for Capital Structure Improvement Including a Proposed Reverse Stock Split and a Note and Warrant Exchange Independent of a Merger Transaction EDEN PRAIRIE, MN - ( NewMediaWire ) - June 26, 2024 - SANUWAVE Health, Inc. (the “Company”...
SANUWAVE pays off $6.3 million Celularity note and interest for $2.075 million SEPA merger outside date to be extended to June 30, 2024 Combined entity has applied to list on Cboe BZX Exchange, Inc. EDEN PRAIRIE, MN - ( NewMediaWire ) - June 04, 2024 - SANUWAVE...